StockNews.AISignal intelligence
Company intelligence

MEDS

TRxADE HEALTH, Inc. · NASDAQ · Healthcare

Price$2.23-3.04% · −$0.07
Market cap10.02MEquity value
P / E0.0Trailing ratio
Volume346.78KLatest session
Market data

MEDS price chart

TradingView
Related signals
1 min delayed

Browse public MEDS signals with their source context and measured market impact. Open any signal for its permanent analysis page.

MEDSSep 28, 2026-11.35% since signal

MEDS rallies on Health Lives Here app; 2026 Long COVID, 2027 digital twin plans

DataMeds AI launched Health Lives Here with Tollo Health and the NFL Alumni Association, uniting telehealth, at-home pharmacy via Corexa Health, wearables data, and an AI health coach for GLP-1 users. The company plans Long COVID expansion in Q4 2026 and oncology thereafter, backed by Helomics diagnostics and a 2027 digital twin/blockchain roadmap. The news triggered a roughly 32% intraday rally to $4.10, signaling optimism on data-driven healthcare monetization.

View signal analysis
Research

Company intelligence